22 October 2020
1300 794 893
Subscribe

Switzer TV

What happened to the house price crash? Experts explain

On this week's show, Peter Switzer is joined by REA Group's Cameron Kusher, BIS Oxford Economics' Sarah Hunter and Binnari Property's Dominic Cavagnino.

More videos

House price boom in 2021! Believe it baby, believe it!

Wealthi's Stephanie Davies, CBRE's Zelman Ainsworth and Msquared Capital's Paul Miron join Peter Switzer on this week's episode.

Mad about Money Live

Join Peter Switzer and Paul Rickard for a live look at the latest market and money news.

Our experts assess Brainchip, Nearmap, Treasury Wines and tech stocks

Peter Switzer speaks to Burman Invest CIO Julia Lee, Shaw and Partners Senior Investment Adviser Adam Dawes, Yellow Brick Road Chairman Mark Bouris, McPherson's CEO Laurie McAllister and Switzer Report co-founder Paul Rickard.

My knee replacement

Dr Ross Walker shares his own experience of having a total knee replacement.

Is Mark Bouris optimistic on property? Plus, Tim Gurner says house prices will rebound!

On this week's show: Yellow Brick Road's Mark Bouris, property developer Tim Gurner and economist Dr Andrew Wilson.

Mad about Money Live

Tune in to find out the latest money and market news with Peter Switzer and Paul Rickard.

We pinpoint some tech stocks you don't want to ignore!

Peter Switzer is joined by Burman Invest's Julia Lee, Medallion's Michael Wayne, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

The link between COVID-19 and heart disease

Dr Ross Walker looks at whether there is any connection between the Coronavirus and drugs used to treat cardiovascular disease.

If this is a Recession, how did a house sell for $95 million last week? Could house prices spike in 2021?

SQM Research's Louis Christopher, Sydney Sotheby’s International Realty's Michael Pallier and Upside Realty's James Kirkland share their perspectives on the property market.

Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Peter Switzer is joined by Burman Invest's Julia Lee, Freelancer.com's Matt Barrie, Vanguard's Robin Bowerman and Switzer's Paul Rickard.

Are you taking enough risk?

Peter Switzer and Paul Rickard discuss risk versus return and how it relates to your super.

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2020 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homephoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram